Archive · 12 Dec 2025
Over 3,000 Drug Samples Found Non-Standard in 2024-25
The Union Health Minister, J P Nadda, told the Lok Sabha that in the year 2024-25, out of 1,16,000 drug samples tested, 3,104 were found not to meet the standard quality, and 245 were found to be fake or mixed with harmful substances.
In the previous year, 2023-24, out of 1,06,000 samples, 2,988 were not of standard quality, and 282 were spurious.
The government checks the quality of drugs to make sure they are safe for people to use.
They also check food to ensure it meets safety standards.
The checks are done by the Food Safety Standard Authority of India (FSSAI) and the Central Drugs Standard Control Organisation (CDSCO) along with state regulators.
They pick samples randomly and inspect drug and food companies based on how risky they are.
Over 3,104 drug samples were declared not of standard quality in 2024-25 out of 1,16,000 tested.
245 drug samples were found to be spurious or adulterated in 2024-25.
In 2023-24, 2,988 out of 1,06,000 samples were not of standard quality, and 282 were spurious.
The Food Safety Standard Authority of India (FSSAI) and CDSCO conduct regular surveillance and inspections to ensure compliance with safety standards.
Risk-based inspections of drug manufacturing and testing firms were initiated in December 2022.
- Who
- Union Health Minister J P Nadda
- What
- Over 3,000 drug samples were declared not of standard quality in 2024-25
- When
- 2024-25
- Where
- India
- Why
- To ensure compliance with quality and safety standards under the Food Safety and Standards Act, 2006
- Total Samples Tested (2024-25)
- 1,16,000
- Non-Standard Samples (2024-25)
- 3,104
- Spurious/Adulterated Samples (2024-25)
- 245
- Total Samples Tested (2023-24)
- 1,06,000
- Non-Standard Samples (2023-24)
- 2,988
- Spurious/Adulterated Samples (2023-24)
- 282
- Total Samples Tested (2022-23)
- 96,173
- Non-Standard Samples (2022-23)
- 3,053
- Spurious/Adulterated Samples (2022-23)
- 424